Macrosomia: A Serious Complication of Diabetes in Pregnancy

Epidemiological Aspects of GDM Leading to the Occurrence of Macrosomia

The epidemiology of diabetes, particularly when exacerbated by macrosomia (the condition of giving birth to a larger-than-average baby), is not well understood in India. However, available research suggests a significant correlation between macrosomia and gestational diabetes GDM. In India, the prevalence of macrosomia varies widely, ranging from 0.5% to as high as 15-45% [7]. Some studies have shed light on potential strategies to reduce the incidence of macrosomia. Strengthening prenatal monitoring has been identified as a valuable approach. For example, a study conducted in rural Haryana, India, found that enhancing prenatal care and monitoring could effectively lower the occurrence of macrosomia [8]. Additionally, maintaining good glycemic control among pregnant women is another essential factor in addressing macrosomia. Research indicates that proper management of blood sugar levels during pregnancy can contribute to a reduced prevalence of macrosomia [9].

Pathophysiology of GDM

As GDM is typically caused by chronic insulin resistance during pregnancy, it involves both insulin resistance in the tissues and defective beta cells. β-Cell Dysfunction: The disruption of β-cells is a critical factor in the advancement of diseases like GDM. The main part of these cells is to collect and release insulin in reply to blood glucose levels. It is believed that chronic excess fuel- induced elevated insulin production may be a contributing factor to β-cell dysfunction over an extended period [10]. This dysfunction can manifest at various stages of the insulin production and secretion process, including post- translational modifications, granule storage, pro-insulin synthesis, exocytosis mechanisms, and glucose sensing. Genetic susceptibility plays a role in β-cell dysfunction, with genes like Kcnq1 and Gck being associated with GDM. Minor defects in the β-cell mechanism may become evident during metabolic stress, like pregnancy, highlighting the complexity of this condition’s underlying mechanisms [11]. Insulin resistance increases the dysfunction of β-cells by reducing the uptake of glucose stimulated by insulin, which results in hyperglycemia. This puts stress on β-cells and makes them produce more insulin than usual. Glucotoxicity, the harmful effects of high blood sugar worsen β-cell function and initiates a malicious cycle of hyperglycemia, insulin resistance, and progressively worsening β-cell degeneration [12].

Chronic Insulin Resistance

A condition known as insulin resistance occurs when cells are unable to react to insulin as well. Insulin resistance usually results from a malfunction in the signaling pathways that insulin triggers at the molecular level. The glucose transporter 4 (GLUT4) is not adequately transported to the cell’s plasma membrane as a result of this breakdown. The rate at which insulin promotes the uptake of glucose is significantly reduced when it comes to GLUT4, a critical protein that is in charge of delivering glucose into the cell where it can be used for energy production. More precisely, compared to a normal pregnancy, there is a 54% decrease in the effectiveness of insulin in GDM in promoting the entry of glucose into cells [13]. The pathophysiology of GDM caused by β-cells dysregulation and chronic insulin resistance is illustrated in Figure 1.

Click to enlarge

Pathophysiology of Macrosomia in GDM

Pedersen’s hypothesis, a well-accepted explanation for the pathophysiology of macrosomia [14], revolves around the development of gestational diabetes in some pregnant women. This condition is characterized by elevated blood sugar levels, primarily attributed to two main factors: insulin resistance and poor glucose metabolism during pregnancy. In response to the increased maternal blood sugar levels, the fetal pancreas can produce excessive amounts of insulin. Insulin is a vital hormone responsible for regulating blood sugar levels [15]. The elevated insulin levels in fetal circulation play a vital role in promoting the uptake and utilization of glucose. This essentially means that the fetus absorbs more glucose from the mother’s bloodstream, potentially providing an increased energy source for fetal growth and development [16]. However, excess glucose that the fetus doesn’t immediately use for energy is stored as fat tissue. Therefore, the heightened glucose utilization resulting from fetal hyperinsulinemia can lead to the accumulation of fat tissue in the fetus, ultimately resulting in macrosomia [17]. This condition refers to the birth of an abnormally large infant.

Complications Associated with Macrosomia

Complications for Mothers: Extra-large babies can present more complicated challenges for a vaginal birth. There is a higher chance of protracted labor, in which the baby can become lodged in the birth canal and may need to be extracted using a vacuum or forceps. An unscheduled or emergency cesarean section might be required in certain circumstances. In addition, compared to deliveries of average size babies, there is an increased risk of tears and abrasions to the vaginal tissue during the birthing process. Additionally, there’s an increased chance of the muscle separating the anus from the vagina [18]. In addition, there is a higher risk of uterine atony, a condition in which the uterine muscle may not contract normally, followed by severe bleeding and hemorrhage after delivery. Studies indicate that macrosomic deliveries carry a 3–5 times higher risk of genital tract injury and postpartum hemorrhage [19]. Additionally, there is a high risk of uterine tears along the scar line from the previous surgery if the mother has had a caesarean section.

Issues with the Fetus

Shoulder Dystocia: One of the most significant complications associated with macrosomic babies is shoulder dystocia. It happens when the baby’s head has passed through the birth canal, but one or both shoulders may jam beside the mother’s pelvic bone. This can create a critical situation during delivery, as it can obstruct the baby’s progress down the birth canal [20]. The brachial plexus is a network of nerves that control the actions and sensations of the shoulder, arm, and hand. When a baby experiences shoulder dystocia, the pressure and stretching exerted on the brachial plexus nerves can lead to injury. This injury is known as a brachial plexus injury. The risk of such an injury is much higher in macrosomic babies, according to some estimates, the risk increases by about 20 times when the birth weight exceeds 4,500 grams [21].

Jaundice in Newborns: Newborn jaundice, also known as neonatal jaundice, is a general aspect where a baby’s skin and eyes develop a yellowish hue. This discoloration occurs due to elevated levels of bilirubin in the blood, which is a yellow pigment produced when red blood cells break down. While mild jaundice is frequently observed in newborns, especially in the first few days of life, it can be more prevalent in high birth weight infants, often referred to as macrosomic babies.

One potential reason for the higher occurrence of jaundice in macrosomic babies is their increased need for oxygen. This heightened oxygen demand might trigger the body to stimulate the production of more red blood cells, a process known as erythropoiesis. This is the body’s way of trying to meet the increased oxygen requirements. However, an unintended consequence of this heightened erythropoiesis is the development of polycythemia. An excessive number of red blood cells circulates in the bloodstream of a newborn with polycythemia [22].

Later Complications: Childhood Metabolic Syndrome and Obesity. Numerous research indicates that GDM may be a contributing factor in childhood obesity. There has been proof that prenatal exposure to diabetes can program an offspring’s later development of obesity. When compared to the offspring of prediabetic or nondiabetic women, the offspring of Pima Indian women with type II diabetes and GDM at birth were greater for gestational age at birth and heavier later about five years of age [23]. According to the 6 to 13-year-old multiethnic kids in the Exploring Perinatal Outcomes among Children (EPOCH) trial, revelation to maternal GDM was linked to greater BMI, a larger waist perimeter, more instinctive and hypodermal adipose tissue, and a more unified fat dispersal pattern [24]. Additionally, children and adolescents exposed to maternal GDM in utero showed greater average BMI rises from 27 months to 13 years of age, as well as greater BMI growth velocity beginning at 10–13 years of age. These results imply that the long-term significance of being exposed to GDM in utero may not necessarily be noticeable in the initial years but slightly manifest at puberty, which is another susceptible time for the cause of obesity. Children of diabetic moms are also more likely to develop metabolic syndromes, which raise the risk of stroke, diabetes, and heart disease by coexisting with elevated blood pressure, obesity, hyperglycemia, and abnormal cholesterol levels [25].

Future Aspects: According to a 2022 study, pregnant women with GDM who are insulin-resistant may experience varied pregnancy outcomes, such as macrosomia [26]. A significant increase in macrosomia in the offspring of mothers with GDM has been demonstrated in several studies [27]. According to a study published in 2023, high HbA1c levels are significantly related to macrosomia during GDM pregnancies [28]. New glycation markers are being studied in a clinical trial to potentially predict macrosomia and GDM. The purpose of this trial is to create novel screening methods for macrosomia associated with GDM [29]. A real-time smartphone solution called GDM Health has been developed using mobile technologies to manage women with GDM. With the use of this technology, blood glucose levels may be remotely monitored, and patients can receive tailored feedback [30].